Evidence map›Paper›PMID 41540024›Full record

ArticleNature communications2026

Control of telomerase recruitment and end protection by independent shelterin components.

Ranjodh Sandhu, Gianna M Tricola, Si Young Lee, Andy Tran, Eros Lazzerini Denchi

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Fission yeast RPA-TERT-Tpz1bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ranjodh SandhuLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Gianna M TricolaLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Si Young LeeLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Andy TranConfocal Microscopy Core Facility, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2388-7121
Eros Lazzerini DenchiLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA. eros.lazzerinidenchi@nih.gov.ORCID http://orcid.org/0000-0001-5378-4644

Funding

Mechanism of end protection in stem cellsZIABC012015 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LAZZERINI DENCHI, EROS · 2020 to 2025
$4.0M
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 1ZIABC011815U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) ZIABC012015
6 · The paper itself

Abstract

Telomeres are proposed to alternate between "closed" states, in which chromosome ends are protected from DNA damage signaling and inaccessible to telomerase, and "open" states, where they become accessible for telomerase mediated elongation but less protected. Whether these states reflect distinct molecular mechanisms or mutually exclusive structural conformations remains unclear. Here, we develop a single-cell assay to monitor telomerase activity in mouse embryonic stem cells. Using this approach, we demonstrate that the shelterin component TPP1 is essential for telomerase recruitment via its interaction with TIN2, independently of POT1. In contrast, POT1 is dispensable for telomerase function but required for telomere end protection, acting independently of TPP1. These findings challenge the classical open-closed telomere model and reveal that telomerase recruitment and end protection are mediated by genetically and molecularly separable mechanisms.

Indexed as

TelomeraseTelomereTelomere-Binding ProteinsAnimalsDNA DamageMiceMouse Embryonic Stem CellsShelterin ComplexAcd protein, mousePOT1 protein, mouseShelterin ComplexTelomeraseTelomere-Binding ProteinsTinf2 protein, mouse

Identifiers

PMID41540024
PMCPMC12913867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.